Patent: 7,449,184
✉ Email this page to a colleague
Summary for Patent: 7,449,184
Title: | Fixed dosing of HER antibodies |
Abstract: | The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab. |
Inventor(s): | Allison; David E. (San Mateo, CA), Bruno; Rene (Marseilles, FR), Lu; Jian-Feng (Foster City, CA), Ng; Chee M. (San Mateo, CA) |
Assignee: | Genentech, Inc. (South San Francisco, CA) |
Application Number: | 11/154,091 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,449,184 |
Patent Claims: | see list of patent claims |
Details for Patent 7,449,184
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2025-01-21 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2025-01-21 |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2025-01-21 |
Genentech, Inc. | PERJETA | pertuzumab | Injection | 125409 | 06/08/2012 | ⤷ Try a Trial | 2025-01-21 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |